Fisher & Paykel Healthcare Corp Ltd
FPH: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|.Z^ | LOCK|#LyB | LOCK|?<vRb%! |
Fisher & Paykel Healthcare Earnings: Solid Hospital Consumables Sales and Margin Expansion
Fisher & Paykel Healthcare's fiscal 2025 underlying EBIT grew 28%, driven by 18% higher hospital consumables sales and operating leverage. Gross margin was a highlight, expanding 130 basis points to 63% on manufacturing efficiencies and reduced freight costs.
